Taken together, these studies suggest that the immune mediated upregulation of TNFα in the DRG and SC may be a critical upstream signaling pathway that regulates MS pain induction by governing CX3CL1 expression. The gene discussed is CX3CL1; the disease is myeloid sarcoma.